You can buy or sell Vericel and other stocks, options, and ETFs commission-free!
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. Read More The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA. The listed name for VCEL is Vericel Corporation Common Stock.
52 Week High
52 Week Low
— per share
Available Nov 5, Pre-Market